Article Topic
Counterfeit Medicine News for the Week of September 21, 2020
In PSM’s round-up this week: HHS defies 20 years of expertise and guidance and recent negative feedback to finalize regulations for state-based Canadian drug importation programs, forward movement on the Safe Therapeutics Act, and more #covidscam and counterfeit drug news.
[...]HHS Secretary Sent Congress The Certification To Allow Canadian Drug Importation
On September 23, 2020, Department of Health and Human Services Alex Azar submitted a letter to House Minority Leader Kevin McCarthy certifying that Canadian drug importation would pose not additional threats to consumers and would save Americans a significant amount of money on prescription drugs.
[...]Trump Administration Defies 20 Years of FDA Expertise and Guidance in Finalizing Politically Motivated Drug Importation Rule
Trump Administration Defies 20 Years of FDA Expertise and Guidance in Finalizing Politically Motivated Drug Importation Rule Washington, D.C. (September 24, 2020) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the Trump Administration’s Final Rule issued today on the importation of prescription drugs: “With 40…
[...]Final regulations released governing Canadian drug importation
On September 24th, 2020 the U.S. Department of Health and Human Services released a draft of finalized rulemaking for Importation of Prescription Drugs. Watch this space for the most up-to-date news.
[...]September 9, 2020 video: 1,000 Fake Pills per bottle – a bust in Toronto
Last June, police in Ontario, Canada carried out Project Javelin, shutting down a huge counterfeiting operation that manufactured hundreds of thousands of fentanyl pills disguised as Oxycocet, a Health Canada-approved generic oxycodone and acetaminophen product with the same ingredients as Percocet.
Update: Executive Director Shabbir Safdar followed up with retired Chief Superintendent of the Ontario Police Don Bell to talk about the impact these criminals could have had. Watch that interview in our September 23rd video, “Deadly Pills in Ontario.”
[...]Counterfeit Medicine News for the Week of September 14, 2020
In PSM’s round-up this week: 520,000 fake medical masks seized by Customs and Border Protection, another fake online pharmacy case, and a flood of news about counterfeit pills made with fentanyl.
[...]FDA Alert: Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency
Risk Statement: Patients being treated for hypothyroidism (underactive thyroid), who receive sub potent NP Thyroid®, may experience signs and symptoms of hypothyroidism (underactive thyroid) which may include, fatigue, increased sensitivity to cold, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland and/or unexplained weight gain or difficulty losing weight. There is reasonable risk of serious injury in newborn infants or pregnant women with hypothyroidism including early miscarriage, fetal hyperthyroidism, and/or impairments to fetal neural and skeletal development. In elderly patients and patients with underlying cardiac disease toxic cardiac manifestations of hyperthyroidism may occur, such as cardiac pain, palpitations or cardiac arrhythmia. To date, Acella has received four reports of adverse events for these lot numbers possibly related to this recall.
[...]Counterfeit Medicine News for the Week of September 7, 2020
In PSM’s round-up this week: $132 million in losses from #covidscams since March, fake online pharmacies selling counterfeit and non-FDA approved opioids, Operation Quack Hack, and more.
[...]Counterfeit Medicine News for the Week of August 31, 2020
In PSM’s round-up this week: outrageous COVID-19-related financial fraud, fake treatments, and the week in deadly counterfeit pills.
[...]RLC Labs, Inc., Issues Voluntary Nationwide Recall of All Lots of Nature-Throid® and WP Thyroid® with Current Expiry Due to Sub Potency
Risk Statement: Patients being treated for hypothyroidism (underactive thyroid), who receive sub potent Nature-Throid® or WP Thyroid®, may experience signs and symptoms of hypothyroidism (underactive thyroid) which may include, fatigue, increased sensitivity to cold, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland and/or unexplained weight gain or difficulty losing weight.
[...]